It can be concluded from the research results that, for gastric cancer among digestive system tumors, the therapeutic effects of ISL mediated by the energy targets GLUT4/PDHK1 and ISL-17 are its unique manifestations that distinguish it from other digestive system tumors (Figure 3). Here, PDK1 is linked to digestive system neoplasm.